Jupiter Neurosciences (JUNS) Stock: Buy, Sell, or Hold?
JUNS - Jupiter Neurosciences, Inc. Common Stock
$2.98
0.40 (15.50%)
â˛
5d:
+2.58%
30d:
+3.29%
90d:
+2525.55%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 13, 2026
19d
Get Alerted When JUNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: JUNS is fairly priced but lacks strong directional signals. At 32.0% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: JUNS is fairly priced but lacks strong directional signals. At 32.0% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: JUNS is currently trading at $2.98, which is considered slightly high relative to its 30-day fair value range of $2.60 to $3.09. From a valuation perspective, the stock is trading at a premium (Forward PE: 49.7) compared to its historical average (21.6). At these levels, the market is pricing in 32.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, JUNS is in a strong uptrend. Immediate support is located at $2.55, while resistance sits at $3.50. The stock is showing strong short-term momentum, up 15.5% recently.
Market Sentiment: JUNS scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+906.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JUNS is in a strong uptrend. Immediate support is located at $2.55, while resistance sits at $3.50. The stock is showing strong short-term momentum, up 15.5% recently.
Market Sentiment: JUNS scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+906.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.60 -
$3.09
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.9%
All Signals
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.5%)
- BULLISH: Trading 906.7% below Wall St target ($30.00)
- BEARISH: Market expects 32.0% growth - appears too optimistic based on history
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.60 -
$3.09
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.55
Resistance Level
$3.50
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
49.67
Wall Street Target
$30.00
(+906.7%)
Valuation Premium vs History
+32.0% premium
PE vs Historical
49.7 vs 21.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+32.0%
(market-implied from PE analysis)
1-Year Target
$3.93
(+32%)
2-Year Target
$5.19
(+74%)
3-Year Target
$6.85
(+130%)
3-Yr Target (if PE normalizes)
(PE: 50â22)
PE COMPRESSION
$2.98
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 23, 2026 9:34 PM ET
Data refreshes hourly during market hours. Next update: 10:34 PM
Data refreshes hourly during market hours. Next update: 10:34 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JUNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$571 | 58 HOLD |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$369 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$144 | 75 BUY |
